lotilaner elanco 225 mg chewable tablets for dogs (>5.5–11 kg)
elanco gmbh - lotilaner - chewable tablet - ectoparasiticide - dogs
lotilaner elanco 450 mg chewable tablets for dogs (>11–22 kg)
elanco gmbh - lotilaner - chewable tablet - ectoparasiticide - dogs
lotilaner elanco 900 mg chewable tablets for dogs (>22–45 kg)
elanco gmbh - lotilaner - chewable tablet - ectoparasiticide - dogs
imrestor
elanco gmbh - pegbovigrastim - colony stimulating factors, immunostimulants, antineoplastic agents - cattle (cows and heifers); cattle - as an aid in a herd management programme, to reduce the risk of clinical mastitis in periparturient dairy cows and heifers during the 30 days following calving.
lotilaner elanco 12 mg chewable tablets for cats (0.5–2.0 kg)
elanco gmbh - lotilaner - chewable tablet - ectoparasiticide - cats
lotilaner elanco 48 mg chewable tablets for cats (>2.0–8.0 kg)
elanco gmbh - lotilaner - chewable tablet - ectoparasiticide - cats
increxxa
elanco gmbh - tulathromycin - antibacterials for systemic use - cattle; pigs; sheep - cattle: treatment and metaphylaxis of bovine respiratory disease (brd) associated with mannheimia haemolytica, pasteurella multocida, histophilus somni and mycoplasma bovis susceptible to tulathromycin. the presence of the disease in the herd should be established before metaphylactic treatment.treatment of infectious bovine keratoconjunctivitis (ibk) associated with moraxella bovis susceptible to tulathromycin.pigs: treatment and metaphylaxis of swine respiratory disease (srd) associated with actinobacillus pleuropneumoniae, pasteurella multocida, mycoplasma hyopneumoniae, haemophilus parasuis and bordetella bronchiseptica susceptible to tulathromycin. the presence of the disease in the herd should be established before metaphylactic treatment. the product should only be used if pigs are expected to develop the disease within 2–3 days.sheep: treatment of the early stages of infectious pododermatitis (foot rot) associated with virulent dichelobacter nodosus requiring systemic treatment.
comfortis
elanco gmbh - spinosad - other ectoparasiticides for systemic use - dogs; cats - treatment and prevention of flea infestations (ctenocephalides felis).the preventive effect against re-infestations is a result of the adulticidal activity and the reduction in egg production and persists for up to 4 weeks after a single administration of the product.the veterinary medicinal product can be used as part of a treatment strategy for the control of flea allergy dermatitis (fad).
fortekor plus
elanco gmbh - benazepril hydrochloride, pimobendan - ace inhibitors, combinations - dogs - for the treatment of congestive heart failure due to atrioventricular valve insufficiency or dilated cardiomyopathy in dogs.
kexxtone
elanco gmbh - monensin (as monensin sodium) - drugs for prevention and/or treatment of acetonemia - cattle (cows and heifers) - for the reduction in the incidence of ketosis in the peri-parturient dairy cow/heifer which is expected to develop ketosis.